CROT | Carnitine O-octanoyltransferase | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYBB | Cytochrome b-245, beta polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
DERL1 | Derlin 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EPB41 | Erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FAM8A1 | Family with sequence similarity 8, member A1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
FXN | Frataxin | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
FZD1 | Frizzled family receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLE1 | GLE1 RNA export mediator | Disease related genes Potential drug targets Transporters
| | | | | Expressed in all |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRM1 | Glutamate receptor, metabotropic 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
HSPA1B | Heat shock 70kDa protein 1B | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Transporters
| | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNIP4 | Kv channel interacting protein 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK5 | Potassium channel, subfamily K, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LETM1 | Leucine zipper-EF-hand containing transmembrane protein 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MAGOH | Mago-nashi homolog, proliferation-associated (Drosophila) | Transporters
| | | | | Expressed in all |
MCL1 | Myeloid cell leukemia sequence 1 (BCL2-related) | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MICU1 | Mitochondrial calcium uptake 1 | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |